~ 090811 The Little-Known Link Between Bone Health and Total Health - References

~ 090811 The Little-Known Link Between Bone Health and Total Health - References
References

1. Clemens TL, Karsenty G. The osteoblast: An insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011 Apr;26(4):677-80.

2. Kim YS, Paik IY, Rhie YJ, Suh SH. Integrative physiology: defined novel metabolic roles of osteocalcin. J Korean Med Sci. 2010 Jul;25(7):985-91.

3. Confavreux CB. Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int Suppl. 2011 Apr (121):S14-9.

4. Available at: http://emedicine.medscape.com/article/1254517-overview. Accessed May 13, 2011.

5. US Department of Health and Human Services. Office of the Surgeon General. "Bone Health and Osteoporosis: A Report of the Surgeon General." October 14, 2004.

6. Grabowski P. Physiology of bone. Endocr Dev. 2009;16:32-48.

7. Simon LS. Osteoporosis. Clin Geriatr Med. 2005 Aug;21(3):603-29, viii.

8. London G, Coyne D, Hruska K, Malluche HH, Martin KJ. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol. 2010 Dec;74(6):423-32.

9. Hinoi E. Control of bone remodeling by nervous system. Regulation of glucose metabolism by skeleton. Tangent point with nervous system. Clin Calcium. 2010 Dec;20(12):1814-9.

10. Wolf G. Energy regulation by the skeleton. Nutr Rev. 2008 Apr;66(4):229-33.

11. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010 Jul 23;142(2):296-308.

12. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2011 Apr 29.

13. Gravenstein KS, Napora JK, Short RG, et al. Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. J Clin Endocrinol Metab. 2011 Mar 9.

14. Enriori PJ, Evans AE, Sinnayah P, Cowley MA. Leptin resistance and obesity. Obesity (Silver Spring). 2006 Aug;14 Suppl 5:254S-258S.

15. Wannamethee SG, Tchernova J, Whincup P, et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2007 Apr;191(2):418-26.

16. Henriksen JH, Holst JJ, Moller S, Andersen UB, Bendtsen F, Jensen G. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. Clin Sci (Lond). 2000 Dec;99(6):527-34.

17. Soderberg S, Stegmayr B, Ahlbeck-Glader C, Slunga-Birgander L, Ahren B, Olsson T. High leptin levels are associated with stroke. Cerebrovasc Dis. 2003;15(1-2):63-9.

18. Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 2011Jun;54(6):1291-7.

19. Vermeer C, Theuwissen E. Vitamin K, osteoporosis and degenerative diseases of ageing. Menopause Int. 2011 Mar;17(1):19-23.

20. Demer LL, Tintut Y. Mechanisms linking osteoporosis with cardiovascular calcification. Curr Osteoporos Rep. 2009 Jul;7(2):42-6.

21. Hjortnaes J, Butcher J, Figueiredo JL, et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J. 2010 Aug;31(16):1975-84.

22. Kaats GR, Preuss HG, Croft HA, Keith SC, Keith PL. A comparative effectiveness study of bone density changes in women over 40 following three bone health plans containing variations of the same novel plant-sourced calcium. Int J Med Sci. 2011;8(3):180-91.

23. Kim MH, Yeon JY, Choi MK, Bae YJ. Evaluation of magnesium intake and its relation with bone quality in healthy young Korean women. Biol Trace Elem Res. 2011 Apr 5.

24. Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr. 2006;46(8):621-8.

25. Cashman KD. Calcium intake, calcium bioavailability and bone health. Br J Nutr. 2002 May;87 Suppl 2:S169-77.

26. Spangler M, Phillips BB, Ross MB, Moores KG. Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. Am J Health Syst Pharm. 2011 Feb 15;68(4):309-18.

27. Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf). 2010 Sep;73(3):277-85.

28. Ferrar L, van der Hee RM, Berry M, et al. Effects of calcium-fortified ice cream on markers of bone health. Osteoporos Int. 2010 Dec 18.

29. Chaturvedi P, Mukherjee R, McCorquodale M, Crawley D, Ashmead S, Guthrie N. Comparison of calcium absorption from various calcium-containing products in healthy human adults: a bioavailability study. FASEB J. 2006 Mar;20(Meeting Abstract Supplement):A1063.

30. Patrick L. Comparative absorption of calcium sources and calcium citrate malate for the prevention of osteoporosis. Altern Med Rev. 1999 Apr;4(2):74-85.

31. Available at: http://lpi.oregonstate.edu/infocenter/minerals/calcium/. Accessed May 12, 2011.

32. Ross AC, Manson JE, Abrams SA, et al. The 2011 dietary reference intakes for calcium and vitamin d: what dietetics practitioners need to know. J Am Diet Assoc. 2011 Apr;111(4):524-7.

33. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood). 2010 Sep;235(9):1034-45.

34. Bacchetta J, Ranchin B, Dubourg L, Cochat P. Vitamin D revisited: a cornerstone of health? Arch Pediatr. 2010 Dec;17(12):1687-95.

35. Kidd PM. Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy. Altern Med Rev. 2010 Sep;15(3):199-222.

36. Verhave G, Siegert CE. Role of vitamin D in cardiovascular disease. Neth J Med. 2010 Mar;68(3):113-8.

37. Querales MI, Cruces ME, Rojas S, Sanchez L. Association between vitamin D deficiency and metabolic syndrome. Rev Med Chil. 2010 Oct;138(10):1312-8.

38. Petchey WG, Hickman IJ, Duncan E, et al. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol. 2009;10:41.

39. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine. 2010 Dec;77(6):552-7.

40. Edlich RF, Mason SS, Reddig JS, Gubler K, Long Iii WB. Revolutionary advances in the diagnosis of vitamin D deficiency. J Environ Pathol Toxicol Oncol. 2010;29(2):85-9.

41. Grant WB, Schwalfenberg GK, Genuis SJ, Whiting SJ. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res. 2010 Aug;54(8):1172-81.

42. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010 Apr 15;171(8):903-8.

43. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, Marz W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res. 2010 Aug;54(8):1103-13.

44. Horani M, Dror A, Holland D, Caporaso F, Sumida KD, Frisch F. Prevalence of Vitamin D(3) Deficiency in Orange County Residents. J Community Health. 2011 Feb 13.

45. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets. 2011 Jan;12(1):4-18.

46. Faloon W. Startling findings about vitamin D levels in Life Extension® members. Life Extension Magazine®. 2010 Jan;16(1):7-14.

47. Wei MY, Giovannucci EL. Vitamin D and multiple health outcomes in the Harvard cohorts. Mol Nutr Food Res. 2010 Aug;54(8):1114-26.

48. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69(5):842-56.

49. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007 Dec;22 Suppl 2:V64-8.

50. Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011 Feb;31(2):607-11.

51. Kitchin B, Morgan SL. Not just calcium and vitamin D: other nutritional considerations in osteoporosis. Curr Rheumatol Rep. 2007 Apr;9(1):85-92.

52. Tucker KL. Osteoporosis prevention and nutrition. Curr Osteoporos Rep. 2009 Dec;7(4):111-7.

53. Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999 Jul;57(7):227-9.

54. Matsuzaki H. Prevention of osteoporosis by foods and dietary supplements. Magnesium and bone metabolism. Clin Calcium. 2006 Oct;16(10):1655-60.

55. Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res. 2009 Dec;22(4):235-46.

56. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999 Apr;69(4):727-36.

57. Ryder KM, Shorr RI, Bush AJ, et al. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc. 2005 Nov;53(11):1875-80.

58. Aydin H, Deyneli O, Yavuz D, et al. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res. 2010 Feb;133(2):136-43.

59. Toba Y, Kajita Y, Masuyama R, Takada Y, Suzuki K, Aoe S. Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. J Nutr. 2000 Feb;130(2):216-20.

60. Matsuzaki H, Miwa M. Dietary calcium supplementation suppresses bone formation in magnesium-deficient rats. Int J Vitam Nutr Res. 2006 May;76(3):111-6.

61. Bae YJ, Kim MH. Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. Calcif Tissue Int. 2010 Oct;87(4):365-72.

62. Available at: http://www.therapeuticsdaily.com/news/article.cfm?contenttype=sentryarticle&contentvalue=1989790&channelID=26. Accessed May 13, 2011.

63. Luckey AE, Parsa CJ. Fluid and electrolytes in the aged. Arch Surg. 2003 Oct;138(10):1055-60.

64. Passare G, Viitanen M, Torring O, Winblad B, Fastbom J. Sodium and potassium disturbances in the elderly : prevalence and association with drug use. Clin Drug Investig. 2004;24(9):535-44.

65. McCarty MF. Rationale for a novel nutraceutical complex K-water': potassium taurine bicarbonate (PTB). Med Hypotheses. 2006;67(1):65-70.

66. Rico H, Aznar L, Hernandez ER, et al. Effects of potassium bicarbonate supplementation on axial and peripheral bone mass in rats on strenuous treadmill training exercise. Calcif Tissue Int. 1999 Sep;65(3):242-5.

67. Wallin R, Schurgers L, Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res. 2008;122(3):411-7.

68. Fodor D, Albu A, Poanta L, Porojan M. Vitamin K and vascular calcifications. Acta Physiol Hung. 2010 Sep;97(3):256-66.

69. Yamaguchi M, Uchiyama S, Tsukamoto Y. Inhibitory effect of menaquinone-7 (vitamin K2) on the bone-resorbing factors-induced bone resorption in elderly female rat femoral tissues in vitro. Mol Cell Biochem. 2003 Mar;245(1-2):115-20.

70. Yamaguchi M, Weitzmann MN. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-kappaB activation. Int J Mol Med. 2011 Jan;27(1):3-14.

71. Takemura H. Prevention of osteoporosis by foods and dietary supplements. "Kinnotsubu honegenki": a fermented soybean (natto) with reinforced vitamin K2 (menaquinone-7). Clin Calcium. 2006 Oct;16(10):1715-22.

72. Tsukamoto Y. Studies on action of menaquinone-7 in regulation of bone metabolism and its preventive role of osteoporosis. Biofactors. 2004;22(1-4):5-19.

73. van Summeren MJ, Braam LA, Lilien MR, Schurgers LJ, Kuis W, Vermeer C. The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr. 2009 Oct;102(8):1171-8.

74. Forli L, Bollerslev J, Simonsen S, et al. Dietary vitamin K2 supplement improves bone status after lung and heart transplantation. Transplantation. 2010 Feb 27;89(4):458-64.

75. Inoue T, Fujita T, Kishimoto H, et al. Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab. 2009;27(1):66-75.

76. Shea MK, Booth SL. Update on the role of vitamin K in skeletal health. Nutr Rev. 2008 Oct;66(10):549-57

77. Reese AM, Farnett LE, Lyons RM, Patel B, Morgan L, Bussey HI. Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy. 2005 Dec;25(12):1746-51.

78. Lurie Y, Loebstein R, Kurnik D, Almog S, Halkin H. Warfarin and vitamin K intake in the era of pharmacogenetics. Br J Clin Pharmacol. 2010 Aug;70(2):164-70.

79. Schaafsma A, de Vries PJ, Saris WH. Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr. 2001 May;41(4):225-49.

80. Miggiano GA, Gagliardi L. Diet, nutrition and bone health. Clin Ter. 2005 Jan-Apr;156(1-2):47-56.

81. Nielsen FH, Hunt CD, Mullen LM, Hunt JR. Effect of dietary boron on mineral, estrogen,and testosterone metabolism in postmenopausal women. FASEB J. 1987 Nov;1(5):394-7.

82. Hegsted M, Keenan MJ, Siver F, Wozniak P. Effect of boron on vitamin D deficient rats. Biol Trace Elem Res. 1991 Mar;28(3):243-55.

83. Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr. 2006;46(8):621-8.

84. Scorei R, Cimpoiasu VM, Iordachescu D. In vitro evaluation of the antioxidant activity of calcium fructoborate. Biol Trace Elem Res. 2005 Nov;107(2):127-34.


Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.